<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>00841683121473</udiDi>
    <basicUdiDi>008416831351M-1CE</basicUdiDi>
    <tradeName>SV40 (MRQ-4) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>351M-15</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:30:00.340Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683121480</udiDi>
    <basicUdiDi>008416831352M-9D5</basicUdiDi>
    <tradeName>Napsin A (MRQ-60) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>352M-94</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:30:00.321Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683121497</udiDi>
    <basicUdiDi>008416831352M-9D5</basicUdiDi>
    <tradeName>Napsin A (MRQ-60) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>352M-96</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.991Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683121527</udiDi>
    <basicUdiDi>008416831354R-1DU</basicUdiDi>
    <tradeName>TFE3 (MRQ-37) Rabbit Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>354R-14</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.973Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683121534</udiDi>
    <basicUdiDi>008416831354R-1DU</basicUdiDi>
    <tradeName>TFE3 (MRQ-37) Rabbit Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>354R-15</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.955Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683121541</udiDi>
    <basicUdiDi>008416831354R-1DU</basicUdiDi>
    <tradeName>TFE3 (MRQ-37) Rabbit Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>354R-16</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.932Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683121558</udiDi>
    <basicUdiDi>008416831354R-1DU</basicUdiDi>
    <tradeName>TFE3 (MRQ-37) Rabbit Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>354R-17</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.909Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683121565</udiDi>
    <basicUdiDi>008416831354R-1DU</basicUdiDi>
    <tradeName>TFE3 (MRQ-37) Rabbit Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>354R-18</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.884Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683121640</udiDi>
    <basicUdiDi>008416831367M-1E3</basicUdiDi>
    <tradeName>IgG4 (MRQ-44) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>367M-17</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.863Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683121688</udiDi>
    <basicUdiDi>008416831382M-1DN</basicUdiDi>
    <tradeName>SOX-11 (MRQ-58) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>382M-14</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.835Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683121695</udiDi>
    <basicUdiDi>008416831382M-1DN</basicUdiDi>
    <tradeName>SOX-11 (MRQ-58) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>382M-15</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.814Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683121701</udiDi>
    <basicUdiDi>008416831382M-1DN</basicUdiDi>
    <tradeName>SOX-11 (MRQ-58) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>382M-16</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.788Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683121718</udiDi>
    <basicUdiDi>008416831382M-1DN</basicUdiDi>
    <tradeName>SOX-11 (MRQ-58) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>382M-17</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.769Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683121725</udiDi>
    <basicUdiDi>008416831384R-1EV</basicUdiDi>
    <tradeName>SATB2 (EP281) Rabbit Monoclonal Primary Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>384R-16</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.753Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683121732</udiDi>
    <basicUdiDi>008416831384R-1EV</basicUdiDi>
    <tradeName>SATB2 (EP281) Rabbit Monoclonal Primary Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>384R-17</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.737Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683121749</udiDi>
    <basicUdiDi>008416831384R-1EV</basicUdiDi>
    <tradeName>SATB2 (EP281) Rabbit Monoclonal Primary Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>384R-18</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.719Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683121763</udiDi>
    <basicUdiDi>008416831386R-1FB</basicUdiDi>
    <tradeName>MyoD1 (EP212) Rabbit Monoclonal Primary Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>386R-14</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.697Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683121770</udiDi>
    <basicUdiDi>008416831386R-1FB</basicUdiDi>
    <tradeName>MyoD1 (EP212) Rabbit Monoclonal Primary Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>386R-15</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.674Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683121787</udiDi>
    <basicUdiDi>008416831386R-1FB</basicUdiDi>
    <tradeName>MyoD1 (EP212) Rabbit Monoclonal Primary Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>386R-16</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.651Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683121794</udiDi>
    <basicUdiDi>008416831386R-1FB</basicUdiDi>
    <tradeName>MyoD1 (EP212) Rabbit Monoclonal Primary Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>386R-17</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.632Z</lastUpdated>
  </row>
</eudamedExport>